Current position of 5HT3 antagonists and the additional value of NK1 antagonists; a new class of antiemetics.

Br J Cancer · 2003 · PMC2741127 · PMID 12799621

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

There was also a numerical advantage for complete control of emesis on day 1 in favour of the CJ-11,974 containing group, 86 vs 67%, but this difference did not reach statistical significance with this limited number of patients.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.